Home › Funds › Jones Hill Capital LP › TNXP

Jones Hill Capital LP position in TNXP

TONIX PHARMACEUTICALS HLDG C · Health Care

Jones Hill Capital LP reported holding 563,739 shares of TNXP (TONIX PHARMACEUTICALS HLDG C) in its Q3 2026 13F filing — a position valued at US$5.5M, representing 0.93% of its reported portfolio and ranking #24 among its reported holdings. Jones Hill Capital LP has disclosed TNXP holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)563.74K sh
Reported value held$5.49M
Portfolio Weight0.93%
First reportedQ1 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's TNXP position evolved

Jones Hill Capital LP first disclosed a stake in TNXP in Q1 2026 at 452,116 shares (US$6.2M). The position peaked in Q2 2026 at 625,428 shares, worth US$8.0M. Across 3 filings, Jones Hill Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 563,739 shares valued at US$5.5M — a reduction of -61,689 shares quarter over quarter.. Notable position changes include a 38% increase in Q2 2026 (shares fell 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 452.12K $6.22M New
Q2 2026 625.43K $7.98M Add
Q3 2026 563.74K $5.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNXP and 13F data

TNXP (TONIX PHARMACEUTICALS HLDG C) is a Health Care company. 60 other funds we track also report a position in TNXP — the largest reported positions include Ishara Investments LP (US$4.3M), SUPERSTRING CAPITAL MANAGEMENT LP (US$812K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNXP

All TNXP fund holders →

FAQ

How long has Jones Hill Capital LP held TNXP?

Jones Hill Capital LP has disclosed TNXP holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Jones Hill Capital LP's current position in TNXP?

As of Q3 2026, Jones Hill Capital LP holds 563.74K shares of TNXP (TONIX PHARMACEUTICALS HLDG C), valued at $5.49M, representing 0.93% of its reported portfolio and ranking #24.

Has Jones Hill Capital LP been buying or selling TNXP?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP reduced its position in TNXP. The position peaked in Q2 2026 at 625.43K shares.

Which other funds hold TNXP?

Other major institutional holders of TNXP include Ishara Investments LP, SUPERSTRING CAPITAL MANAGEMENT LP, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.